Lindbrook Capital’s MorphoSys AG American Depositary Shares MOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,248
| Closed | – | – | 2955 |
|
|
2024
Q3 | $0 | Sell |
1,248
-8
| -0.6% | -$148 | ﹤0.01% | 2937 |
|
|
2024
Q2 | $22.9K | Buy |
1,256
+8
| +0.6% | +$145 | ﹤0.01% | 1168 |
|
|
2024
Q1 | $22.6K | Buy |
1,248
+96
| +8% | +$1.42K | ﹤0.01% | 1145 |
|
|
2023
Q4 | $11.4K | Sell |
1,152
-68
| -6% | -$500 | ﹤0.01% | 1479 |
|
|
2023
Q3 | $8.2K | Buy |
1,220
+68
| +6% | +$524 | ﹤0.01% | 1510 |
|
|
2023
Q2 | $8.61K | Hold |
1,152
| – | – | ﹤0.01% | 1556 |
|
|
2023
Q1 | $4.56K | Sell |
1,152
-296
| -20% | -$1.3K | ﹤0.01% | 1891 |
|
|
2022
Q4 | $5.18K | Buy |
+1,448
| New | +$6.47K | ﹤0.01% | 1804 |
|
|
2022
Q3 | – | Sell |
-3,448
| Closed | -$17K | – | 2970 |
|
|
2022
Q2 | $17K | Buy |
+3,448
| New | +$19K | ﹤0.01% | 1051 |
|
|
2020
Q1 | – | Sell |
-116
| Closed | -$4K | – | 1885 |
|
|
2019
Q4 | $4K | Hold |
116
| – | – | ﹤0.01% | 1179 |
|
|
2019
Q3 | $3K | Hold |
116
| – | – | ﹤0.01% | 1224 |
|
|
2019
Q2 | $2K | Buy |
+116
| New | +$2.88K | ﹤0.01% | 1278 |
|
Lindbrook Capital's MOR Position: Q4 2024 in Review
Lindbrook Capital sold out of MorphoSys AG American Depositary Shares (MOR) in Q4 2024, closing a stake of 1,248 shares.
Lindbrook Capital first reported a position in MOR in Q2 2019 and held it in 12 quarters. The position peaked at $22.9K in Q2 2024. 0 funds tracked by Wall St. Rank hold MOR as of Q4 2024.
- Lindbrook Capital reported no remaining MorphoSys AG American Depositary Shares position as of Q4 2024 after selling out during the quarter.
- Lindbrook Capital sold 1,248 MorphoSys AG American Depositary Shares shares in Q4 2024.
- Lindbrook Capital first reported a position in MorphoSys AG American Depositary Shares in Q2 2019 and held it in 12 quarters.
- Lindbrook Capital's MorphoSys AG American Depositary Shares position peaked at $22.9K in Q2 2024.
- 0 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q4 2024.
Based on Lindbrook Capital's 13F filing for Q4 2024, filed 6 Feb 2025.